High-Risk Human Papillomavirus Targets Crossroads in Immune Signaling

by Bart Tummers, Sjoerd H. van der Burg
Published 2015-05-01

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy

by Els M. E. Verdegaal, Sjoerd H. van der Burg
Published 2017-09-01

TEIPP peptides: exploration of unTAPped cancer antigens

by Koen A. Marijt, Sjoerd H. Van Der Burg, Thorbald van Hall
Published 2019-08-01

The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma

by Marij J. P. Welters, Saskia J. Santegoets, Sjoerd H. van der Burg
Published 2020-12-01

Future Challenges in Cancer Resistance to Immunotherapy

by Marit J. van Elsas, Thorbald van Hall, Sjoerd H. van der Burg
Published 2020-04-01

Monitoring of the Immune Dysfunction in Cancer Patients

by Saskia J. A. M. Santegoets, Marij J. P. Welters, Sjoerd H. van der Burg
Published 2016-09-01

Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies

by R. Vermeij, N. Leffers, S. H. van der Burg, C. J. Melief, T. Daemen, H. W. Nijman
Published 2011-01-01

Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types

by Monique K. van der Kooij, Frank M. Speetjens, Sjoerd H. van der Burg, Ellen Kapiteijn
Published 2019-06-01

Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections

by Eleni Panagioti, Eleni Panagioti, Paul Klenerman, Lian N. Lee, Sjoerd H. van der Burg, Ramon Arens
Published 2018-02-01

T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy

by Elien M. Doorduijn, Marjolein Sluijter, Koen A. Marijt, Bianca J. Querido, Sjoerd H. van der Burg, Thorbald van Hall
Published 2018-03-01

The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection.

by Eleni Panagioti, Anke Redeker, Suzanne van Duikeren, Kees Lmc Franken, Jan Wouter Drijfhout, Sjoerd H van der Burg, Ramon Arens
Published 2016-09-01

Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies

by Tom J. Harryvan, Els M. E. Verdegaal, James C. H. Hardwick, Lukas J. A. C. Hawinkels, Sjoerd H. van der Burg
Published 2019-11-01

Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling

by Koen A. Marijt, Marjolein Sluijter, Laura Blijleven, Sofie H. Tolmeijer, Ferenc A. Scheeren, Sjoerd H. van der Burg, Thorbald van Hall
Published 2019-06-01

T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1b with TAP-Independent Peptides Are Semi-Invariant Lymphocytes

by Elien M. Doorduijn, Marjolein Sluijter, Bianca J. Querido, Ursula J. E. Seidel, Claudia C. Oliveira, Sjoerd H. van der Burg, Thorbald van Hall
Published 2018-01-01

Monalizumab: inhibiting the novel immune checkpoint NKG2A

by Thorbald van Hall, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, Eric Vivier
Published 2019-10-01

EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.

by Wenbo Ma, Fernando Concha-Benavente, Saskia J A M Santegoets, Marij J P Welters, Ilina Ehsan, Robert L Ferris, Sjoerd H van der Burg
Published 2018-01-01

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses

by S. J. Santegoets, C. L. Duurland, E. S. Jordanova, J. J. van Ham, I. Ehsan, S. L. van Egmond, M. J. P. Welters, S. H. van der Burg
Published 2019-01-01

Demarcated thresholds of tumor-specific CD8 T cells elicited by MCMV-based vaccine vectors provide robust correlates of protection

by Elham Beyranvand Nejad, Robert B. Ratts, Eleni Panagioti, Christine Meyer, Jennifer D. Oduro, Luka Cicin-Sain, Klaus Früh, Sjoerd H. van der Burg, Ramon Arens
Published 2019-01-01

Inhibition of CSF-1R supports T-cell mediated melanoma therapy.

by Marjolein Sluijter, Tetje C van der Sluis, Pieter A van der Velden, Mieke Versluis, Brian L West, Sjoerd H van der Burg, Thorbald van Hall
Published 2014-01-01

Human papillomavirus (HPV) downregulates the expression of IFITM1 and RIPK3 to escape from IFNγ and TNFα-mediated anti-proliferative effects and necroptosis

by Wenbo Ma, Bart Tummers, Edith M.G. van Esch, Renske Goedemans, Cornelis J.M. Melief, Craig Meyers, Judith M. Boer, Sjoerd H Van Der Burg
Published 2016-11-01